@BlueJays@TD_Canada@27vladdyjr You ought to close the roof AND lock the team out. The pen is worthless, they can’t hit, and have worthless coaching. Thank God I have a decent organization to watch with my hometown Guardians…
@ElhamNasri@ScottBikeethan@JMGardnerMD There is an interesting J Arthroplast 2019 study on ALVAL and TKA. I personally sign these descriptively regardless of site, but know others who would add “consistent with”…
Thank you to all of the Pathologists’ Assistants out there. We thank you for your dedication to helping us be more efficient and effective on a daily basis. #PathAssistDay
@Jaysharav53@01sth02@ScottBikeethan @kells108 @JLHornick@JMcMahonG@SumantaDas_7 I agree with the others who believe this is hemangioma or a hemangioma variant. Unfortunately imaging findings don’t always help with vascular tumors…but how aggressive is this radiographically?
Are you a board certified cytopathologist looking to work with a large group of friendly colleagues? Please consider joining our #cytopath group, which, at 24 cytopathologists, is one of the country’s largest.
Click here to apply in confidence:
https://t.co/WjRsUUDkPf
Very humbled to present the final year of our non-neoplastic bone short course at the @TheUSCAP meeting with these two outstanding pathologists. Seven years after our first short course together we’re still plugging away. Stay tuned for more…@ScottBikeethan@NielsenPetur
Giant cell tumor of bone gone bad….
A frankly malignant GCT of bone with extensive osteosarcomatous differentiation.
H3.3 G34W IHC can be very helpful.
#BSTpath#sarcoma
Bone tumor of a middle aged male involving the metaphysis of the distal tibia with focal cortical erosion. Are ancillary studies needed to establish the dx? What is the most common molecular abnormality (ies)? #BSTpath#pathology@CCFPathRes@reith16